CHAPTER 10 Hepatitis on Dialysis

Slides:



Advertisements
Similar presentations
ANZDATA Registry Annual Report 2013 STOCK AND FLOW CHAPTER 1.
Advertisements

World population: 6.7 billion Global Prevalence Patients per million population (p.m.p.) Global View of ESRD Patients World population 1.2% ESRD~ 7% Haemodialysis7-8%
Factors associated to the prevalence of antibodies to hepatitis C virus in chronic hemodialysis patients in a sample of centers in Puerto Rico, 2005 Marievelisse.
UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.
P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.
Nancy Briggs Kylie Hurst Stephen McDonald CHAPTER 4 METHOD AND LOCATION OF DIALYSIS 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.
CRF Dialysis Access. Dialysis in Saudi Arabia  There are 6700 patients on dialysis in Saudi Arabia  There is 130 haemodialysis centres in Saudi Arabia.
UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients
UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
UK Renal Registry 17th Annual Report Figure Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.
UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PAEDIATRIC CHAPTER 11.
CHAPTER 2 DIALYSIS IN MALAYSIA Goh Bak Leong Lim Yam Ngo Ong Loke Meng Ghazali Ahmad Lee Day Guat Source: 21 st MDTR Report 2013, NRR.
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.
CHAPTER 6: MANAGEMENT OF ANAEMIA IN PATIENTS ON DIALYSIS Philip N. Jeremiah Bee Boon Cheak Ghazali B Ahmad Lim Soo Kun Zawawi B Nordin Source: 21 st MDTR.
UK Renal Registry 15th Annual Report Figure 6.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2011.
UK Renal Registry 16th Annual Report Figure Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
CHAPTER 9: Chronic Kidney Disease – Mineral and Bone DisorderKok Lai Sun Ching Chen Hua Fan Kin Sing Rozina Ghazalli Liew Yew Fong Source: 21 st MDTR Report.
UK Renal Registry 17th Annual Report Figure Box and whisker plot of renal centres’ MRSA rates per 100 dialysis patient years by reporting year.
CHAPTER 8: Blood Pressure Control and Dyslipidaemia in Patients on Dialysis S. Prasad Menon Hooi Lai Seong Lee Wan Tin Sunita Bavanandan Source: 21 st.
Blair Grace Kylie Hurst Stephen McDonald CHAPTER 1 STOCK AND FLOW 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.
UK Renal Registry 16th Annual Report Figure Box and whisker plot of MRSA rates by renal centre per 100 prevalent dialysis patients per year by reporting.
MANAGEMENT OF ANAEMIA IN PATIENTS ON DIALYSIS Philip N. Jeremiah Bee Boon Cheak Ghazali B Ahmad Lim Soo Kun Zawawi B Nordin Source: 20 th MDTR Report 2012,
Chapter 3 Death and Survival on Dialysis Wong Hin Seng Ong Loke Meng Source: 20 th MDTR Report 2012, NRR.
END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND CHAPTER 12.
CHAPTER 2 DIALYSIS IN MALAYSIA Goh Bak Leong Lim Yam Ngo Ong Loke Meng Ghazali Ahmad Lee Day Guat Source: 20 th MDTR Report 2012, NRR.
CHAPTER 8: BLOOD PRESSURE CONTROL AND DYSLIPIDAEMIA S. Prasad Menon Hooi Lai Seong Lee Wan Tin Sunita Bavanandan Source: 20 th MDTR Report 2012, NRR.
Introduction Data Statistical Methods Table 1: Prevalence of Prior Hip Fracture and Incidence of New Hip Fractures and Fractures of Any Type.
USRDS 2000 ADR USRDS Hepatitis B vaccine & antibody among patients & unit staff figure 9.1, dialysis patients, 1997, by network.
END-STAGE KIDNEY DISEASE AMONG 2013 Annual Report - 36th Edition
UK Renal Registry 18th Annual Report
Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive.
First-year death rates by modality figure 8
Prevalence (pmp) of Renal Replacement Therapy
ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.
Total Number of persons Tested
UK Renal Registry 16th Annual Report
UK Renal Registry 19th Annual Report
CHAPTER 5 Paediatric Renal Replacement Therapy
Table 4.1: Cumulative distribution of QoL-Index score in relation to dialysis modality, all dialysis patients
CHAPTER 7 Nutritional Status on Dialysis
Figures & Tables from the textbook.
CHAPTER 3 Death and Survival on Dialysis
METHOD AND LOCATION OF DIALYSIS CHAPTER 4.
CHAPTER 1 All Renal Replacement Therapy In Malaysia
CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition
UK Renal Registry 13th Annual Report
CHAPTER 9 Chronic Kidney Disease – Mineral and Bone Disorder
UK Renal Registry 13th Annual Report
Chapter 5: Graphs & Functions
UK Renal Registry 14th Annual Report
Figure 11-1.
UK Renal Registry 16th Annual Report
2013 Annual Report - 36th Edition
Figure Overview.
Figure Overview.
ANZDATA Registry 41st Annual Report Highlights of End Stage Kidney Disease in Australia and New Zealand Data to 31-Dec-2017.
UK Renal Registry 14th Annual Report
Hepatitis C treatment in patients with kidney disease
Chapter 7 Nutritional status on dialysis
Volume 53, Issue 5, Pages (May 1998)
American Journal of Kidney Diseases
UK Renal Registry 16th Annual Report
E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins 
Chapter 1 Functions.
CHAPTER 10 Hepatitis on Dialysis
CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES
Presentation transcript:

CHAPTER 10 Hepatitis on Dialysis

Table 10.1: Prevalence of positive HBsAg and positive Anti-HCV at annual survey, HD patients 2007-2016

Table 10.2: Prevalence of positive HBsAg and positive Anti-HCV at annual survey, PD patients 2007-2016

Table 10.3: Variation in Proportion of patients with positive HBsAg at annual survey among HD centres, 2007-2016

Figure 10.3: Variation in proportion of patients with positive HBsAg among HD centres, 2016

Table 10.4: Variation in proportion of patients with positive HBsAg at annual survey among PD centres, 2007-2016

Figure 10.4: Variation in proportion of patients with positive HBsAg among PD centres, 2016

Table 10.5: Variation in proportion of patients with positive anti-HCV at annual survey among HD centres, 2007-2016

Figure 10.5: Variation in proportion of patients with positive anti-HCV among HD centres, 2016

Table 10.6: Variation in proportion of patients with positive anti-HCV at annual survey among PD centres, 2007-2016

Figure 10.6: Variation in proportion of patients with positive anti-HCV among PD centres, 2016

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.